Evidence map›Paper›PMID 39591161›Full record

ArticleVaccines2024

Measles-Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations.

Darin Zehrung, Bruce L Innis, Auliya A Suwantika, Mahmoud Ameri, Robin Biellik, James C Birchall, Alejandro Cravioto, Courtney Jarrahian, Lee Fairlie, James L Goodson and 10 more

Abstract read
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Darin ZehrungWorld Health Organization, 1211 Geneva, Switzerland.
Bruce L InnisIndependent Researcher, Haverford, PA 19041, USA.ORCID 0000-0002-1753-7248
Auliya A SuwantikaDepartment of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Bandung 45363, Indonesia.ORCID 0000-0001-8671-2065
Mahmoud AmeriIndependent Researcher, Fremont, CA 9453, USA.
Robin BiellikIndependent Researcher, 1278 La Rippe, Switzerland.
James C BirchallSchool of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff CF10 3NT, UK.ORCID 0000-0001-8521-6924
Alejandro CraviotoDepartamento de Salud Pública, Facultad de Medicina, National Autonomous University of Mexico, Mexico City 04510, Mexico.ORCID 0000-0002-7142-1975
Courtney JarrahianPATH, Seattle, WA 98121, USA.ORCID 0000-0003-3046-6891
Lee FairlieWits RHI, University of Witwatersrand, Johannesburg 2001, South Africa.ORCID 0000-0001-5327-1734
James L GoodsonCenters for Disease Control and Prevention, Atlanta, GA 30333, USA.
Sonali KochharDepartment of Global Health, University of Washington, Seattle, WA 98105, USA.ORCID 0000-0002-1150-5691
Katrina KretsingerIndependent Researcher, Decatur, GA 30033, USA.ORCID 0000-0001-7258-6029
Christopher MorganJHPIEGO, Baltimore, MD 21231, USA.ORCID 0000-0003-0931-5474
Mercy MvunduraPATH, Seattle, WA 98121, USA.ORCID 0000-0002-7711-9558
Niraj RathiPATH, New Delhi 110001, India.
Edward ClarkeMedical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine, Banjul P.O. Box 273, The Gambia.
Jessica Joyce MistilisPATH, Seattle, WA 98121, USA.ORCID 0000-0002-1448-278X
Marie-Chantal UwamweziPATH, 1040 Brussels, Belgium.ORCID 0009-0002-2199-2312
Birgitte GiersingWorld Health Organization, 1211 Geneva, Switzerland.
Mateusz Hasso-AgopsowiczWorld Health Organization, 1211 Geneva, Switzerland.ORCID 0000-0003-4137-4685

Funding

World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clinical trialmeaslesmicropatchrubellavaccines

Identifiers

PMID39591161
PMCPMC11598609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.